Skip to content

Clinical trials

Phase 2 Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Austria Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20063
20072
20082
20092
20121
20141
20151
20161
20181
20192
20202
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Amgen2
Christian Buske2
Merck KGaA, Darmstadt, Germany2
Novartis Pharmaceuticals2
AstraZeneca1
Austrian Breast & Colorectal Cancer Study Group1
Bristol-Myers Squibb1
Centocor, Inc.1
Cogent Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms25
Breast Neoplasms3
Neoplasm Metastasis3
Brain Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Leukemia2
Multiple Myeloma2
Prostatic Neoplasms2
Adenocarcinoma1
Anemia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.